Chun-Yang Chen

The synergy of artificial intelligence and organ-on-a-chip: building a next-generation intelligent engine for drug development.

Drug development has long been constrained by high costs, lengthy timelines, and low success rates, primarily due to the insufficient human physiological fidelity of traditional preclinical models. Artificial intelligence (AI) has accelerated computational drug discovery, but its models inherit training-data bias and a...